On 26 January, Nxt-ID, Inc. (NASDAQ:NXTD) announced the launch of a new corporate website (http://www.nxt-id.com/) as part of its 2015 marketing and branding initiatives for the Wocket™ smart wallet. On Friday shares of Nxt-ID, Inc. (NASDAQ:NXTD) closed at $2.60.
Macquarie upgraded shares of Fifth Third Bancorp (NASDAQ:FITB) from a neutral rating to an outperform rating in a research note released on Wednesday morning. Fifth Third Bancorp (NASDAQ:FITB) in last trading activity advanced 1.40% to close at $18.89. Company weekly performance is 9.19% while its quarterly performance stands at -5.79%. Fifth Third Bancorp (NASDAQ:FITB) is -19.06% away from its 52 week high.
On 4 February, Unilife Corporation (NASDAQ:UNIS) announced the Unilife Corporation (NASDAQ:UNIS) closing of its previously announced public offering in the United States of common stock. Prior to the closing, the underwriters exercised in full their option to purchase an additional 1,650,000 shares of common stock. As a result, Unilife issued a total of 12,650,000 shares in the offering at a public price of $3.75 per share. On last trading day fell -3.36% to close at $4.03. Its volatility for the week is 6.36% while volatility for the month is 8.12%. UNIS’s sales growth for past 5 years was -6.00% and its EPS growth for past 5 years was 0.00%. Unilife Corporation (NASDAQ:UNIS) monthly performance is 11.33%.
On 4 February, FormFactor Inc. (NASDAQ:FORM) reported a loss of $1.9 million in its fourth quarter. The Livermore, California-based company said it had a loss of 3 cents per share. Earnings, adjusted for amortization costs and stock option expense, were 11 cents per share. FormFactor Inc. (NASDAQ:FORM) has 0.70% insider ownership while its institutional ownership stands at 83.80%. In last trading activity company’s stock closed at $8.52.
On 30 January, Zogenix, Inc. (NASDAQ:ZGNX) announced that the US Food and Drug Administration (FDA) approved its new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek. Zogenix, Inc. (NASDAQ:ZGNX) has 11.97% insider ownership while its institutional ownership stands at 69.10%. In last trading activity company’s stock closed at $1.30.